Clinical trial
A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin)
NCT00336323 is registered in ClinicalTrials.gov with Jaeb Center for Health Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin)
- Lead sponsor
- Jaeb Center for Health Research
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2006
- Completion date
- February 29, 2008
- Enrollment
- 121 (actual)
- Sites
- 34
Conditions
As the registry lists them; a condition with its own page is linked.